Handelsbanken Fonder’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,800
| Closed | -$195K | – | 1561 |
|
|
2025
Q1 | $195K | Hold |
24,800
| – | – | ﹤0.01% | 1495 |
|
|
2024
Q4 | $369K | Buy |
24,800
+2,500
| +11% | +$37.2K | ﹤0.01% | 1401 |
|
|
2024
Q3 | $341K | Buy |
22,300
+3,000
| +16% | +$45.9K | ﹤0.01% | 1380 |
|
|
2024
Q2 | $294K | Buy |
19,300
+6,500
| +51% | +$99K | ﹤0.01% | 1395 |
|
|
2024
Q1 | $242K | Hold |
12,800
| – | – | ﹤0.01% | 1451 |
|
|
2023
Q4 | $244K | Buy |
+12,800
| New | +$244K | ﹤0.01% | 1464 |
|
|
2022
Q4 | – | Sell |
-8,500
| Closed | -$222K | – | 1599 |
|
|
2022
Q3 | $222K | Hold |
8,500
| – | – | ﹤0.01% | 1402 |
|
|
2022
Q2 | $215K | Hold |
8,500
| – | – | ﹤0.01% | 1477 |
|
|
2022
Q1 | $268K | Sell |
8,500
-3,800
| -31% | -$120K | ﹤0.01% | 1561 |
|
|
2021
Q4 | $498K | Hold |
12,300
| – | – | ﹤0.01% | 1347 |
|
|
2021
Q3 | $429K | Hold |
12,300
| – | – | ﹤0.01% | 1443 |
|
|
2021
Q2 | $338K | Buy |
+12,300
| New | +$338K | ﹤0.01% | 1591 |
|